Question 1

What is Proteotype Diagnostics?

Accepted Answer

Proteotype Diagnostics is a Entity.

Question 2

How often does Proteotype Diagnostics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was Proteotype Diagnostics first tracked by Ergen?

Accepted Answer

First tracked on Jul 30, 2026.

Question 4

When was Proteotype Diagnostics last mentioned in news?

Accepted Answer

Last active on Jul 30, 2026.

Question 5

What is Proteotype Diagnostics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Proteotype Diagnostics in global news coverage?

Accepted Answer

Attention score of 2, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Proteotype Diagnostics?

Accepted Answer

Proteotype Unveils Alchemi Platform (Jul 30, 2026, 7 articles).

Question 8

How did the "Proteotype Unveils Alchemi Platform" event impact Proteotype Diagnostics?

Accepted Answer

Proteotype is the developer of Alchemi and Enlighten, and this announcement highlights its technological advancement and grant support, potentially boosting its credibility and funding prospects.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.